Table 2.
Necroptosis mechanism in cancer disease.
| Protein | Up/down | Description | Article related to necroptosis | References |
|---|---|---|---|---|
| TNF | Up | Tumor necrosis factor | Fisetin significantly increases TNF and IK expression while decreasing pNF-, and pIK expression | [35] |
| RIPK1 and RIPK3 | Up | Receptor-interacting protein kinase-1 and 3 | In the presence of ZVAD, MCF-7 cells express substantially more RIPK1 and RIPK3 in response to Que than in the absence of ZVAD | [33] |
|
| ||||
| TNFR1 | Up | TNF's receptor following the formation of two TNFR complexes | Cell survival, apoptosis, or necroptosis can result from TNFR1 stimulation caused by damage, cellular stress, or infection | [8, 36] |
| TNF-α, TNFR1, and necroptosis protein expression are all inhibited by PPO, indicating that PPO can protect neurons by preventing TNF-α-induced necroptosis | [37] | |||
|
| ||||
| FADD | Up | Fas-associated protein with death domain (FADD). Activation of MLKL | Necroptosis is caused by caspase-8, FADD, and RIPK3 (complex IIa/b) | [36] |
| FADD expression in HepG2 is reduced by fisetin treatment. FADD protects intestinal epithelial cells from RIP3-induced cell necrosis | [35] | |||
|
| ||||
| MLKL | Up | MLKL (mixed lineage kinase like) after rapid plasma membrane rupture and inflammatory response via DAMP and cytokine release | M1 CM significantly increases expression levels of MLKL, RIPK3, and p-MLKL after quercetin treatment | [36, 38] |